Efficacy of total neoadjuvant chemotherapy in the FLOT regimen in patients with locally advanced gastric and gastroesophageal junction: results of a phase II study ; Эффективность полной неоадъювантной химиотерапии в режиме FLOT у пациентов с местно-распространенным раком желудка и кардиоэзофагеального перехода: результаты исследования II фазы

Συγγραφείς: A. Yu. Anokhin, P. V. Kononets, D. Yu. Kanner, D. L. Stroyakovsky, A. O. Shveykin, A. E. Kalinin, V. Yu. Kirsanov, A. S. Tyulandina, А. Ю. Анохин, П. В. Кононец, Д. Ю. Каннер, Д. Л. Строяковский, А. О. Швейкин, А. Е. Калинин, В. Ю. Кирсанов, А. С. Тюляндина

Πηγή: Surgery and Oncology; Том 14, № 1 (2024); 62-71 ; Хирургия и онкология; Том 14, № 1 (2024); 62-71 ; 2949-5857

Θεματικοί όροι: гастрэктомия, gastroesophageal junction cancer, locally advanced gastric cancer, perioperative chemotherapy, total neoadjuvant chemotherapy, pathomorphological regression, gastrectomy, рак кардиоэзофагеального перехода, местно-распространенный рак желудка, периоперационная химиотерапия, полная неоадъювантная химиотерапия, патоморфологический регресс опухоли

Περιγραφή αρχείου: application/pdf

Relation: https://www.onco-surgery.info/jour/article/view/692/457; Давыдов М.И., Туркин И.Н., Давыдов М.М. Энциклопедия хирургии рака желудка. М.: Эксмо, 2011.; Шаназаров Н.А., Синяков А.Г., Райков Н.С. и др. Различные объемы лимфодиссекции в хирургическом лечении рака желудка. Тюменский медицинский журнал 2010;2:89–92.; Дмитриев Е.Г., Михайлова Н.В. Хирургическое лечение рака желудка: современное состояние и перспективы. Поволжский онкологический вестник 2010;4:74–81.; Catalano V., Labianca R., Beretta G. et al. Gastric cancer. Crit Rev Oncol Hematol 2009;71:127–64. DOI:10.1016/j.critrevonc.2009.01.004; Бесова Н.С., Калинин А.Е., Неред С.Н. и др. Ассоциация онкологов России. Клинические рекомендации по лечению рака желудка. 2020 год. https://oncology-association.ru/wp-content/uploads/2020/09/rak_zheludka.pdf; Cunningham D., Allum W., Stenning S. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20. DOI:10.1056/NEJMoa055531; Al-Batran S.E., Homann N., Pauligk C. et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastrooesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 2019;393(10184):1948–57. DOI:10.1016/S0140-6736(18)32557-1; Бесова Н.С., Болотина Л.В., Гамаюнов С.В. и др. Практические рекомендации по лекарственному лечению рака желудка. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли 2023;13(3):405–24. DOI:10.18027/2224-5057-2023-13-3s2-1-405-424; NCCN Clinical Practice Guidelines in oncology. Gastric cancer. – National Comprehensive Cancer Network, version 2.2022. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf; Ychou M., Boige V., Pignon J. et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. JCO 2011;29(13):1715–21. DOI:10.1200/JCO.2010.33.0597; Mandard A., Dalibard F., Mandard J. et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73(11):2680–6. DOI:10.1002/1097-0142(19940601)73:113.0.co;2-c; Ma J., Jianhui L., Meirui Q. et al. PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N). Diagn Pathol 2018;13(1):91–101. DOI:10.1186/s13000-018-0766-0; Giommoni E., Lavacchi D., Tirino G. et al. Results of the observational prospective RealFLOT study. BMC Cancer 2021;21:1086–96. DOI:10.1186/s12885-021-08768-7; Muro K., Chung H.C., Shankaran V. et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol 2016;17:717–26. DOI:10.1016/S1470-2045(16)00175-3; Smyth E., Wotherspoon A., Peckitt C. et al. Mismatch repair deficiency, microsatellite instability, and survival an exploratory analysis of the medical research council adjuvant gastric infusional chemotherapy (MAGIC) trial. JAMA Oncol 2017;3(9):1197–203. DOI:10.1001/jamaoncol.2016.6762; Сунь Х., Неред С.Н., Трякин А.А. и др. Результаты комбинированного лечения резектабельного рака желудка в зависимости от статуса микросателлитной нестабильности. Тазовая хирургия и онкология 2023;13(2):17–26. DOI:10.17650/2686-9594-2023-13-2-17-26

Διαθεσιμότητα: https://www.onco-surgery.info/jour/article/view/692
https://doi.org/10.17650/2949-5857-2024-14-1-62-71

Маркер проліферації PCNA як прогностичний показник ефективності неоад’ювантної поліхіміотерапії у жінок з місцево-поширеним раком молочної залози

Συγγραφείς: Dumanskiy, Y.V., Bondar, O.V., Tkachenko, O.I., Stoliarchuk, E.A.

Πηγή: TRAUMA; Том 20, № 5 (2019); 78-83
ТРАВМА; Том 20, № 5 (2019); 78-83

Θεματικοί όροι: індекс проліферативної активності, маркер PCNA, селективна внутрішньоартеріальна поліхіміотерапія, ендолімфальна поліхіміотерапія, системна поліхіміотерапія, місцево-поширений рак молочної залози, 03 medical and health sciences, 0302 clinical medicine, индекс пролиферативной активности, селективная внутриартериальная полихимиотерапия, эндолимфатическая полихимиотерапия, системная полихимиотерапия, местно-распространенный рак молочной железы, proliferative activity index, PCNA marker, selective intra-arterial polychemotherapy, endolymphatic polychemotherapy, systemic polychemotherapy, locally advanced breast cancer, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://trauma.zaslavsky.com.ua/article/download/185560/188908
http://trauma.zaslavsky.com.ua/article/view/185560

Hedgehog inhibitor in the treatment of basal cell skin cancer: case report

Συγγραφείς: Sh. I. Musin, N. А. Sharafutdinova, A. V. Sultanbaev, S. V. Osokin, B. A. Ibragimov, K. V. Menshikov, R. T. Ayupov

Πηγή: Опухоли головы и шеи, Vol 11, Iss 1, Pp 109-114 (2021)

Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, местно-распространенный рак кожи, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, базальноклеточный рак кожи, ингибитор сигнального пути hedgehog, RC254-282, 3. Good health

Σύνδεσμος πρόσβασης: https://ogsh.abvpress.ru/jour/article/download/616/468
https://doaj.org/article/cfe738c4ca0e4b659538fb885ede91ba
https://ogsh.abvpress.ru/jour/article/download/616/468
https://ogsh.abvpress.ru/jour/article/view/616

Clinical case of surgical treatment of advanced basal cell carcinoma of the skin on the face ; Клинический случай хирургического лечения распространенного базальноклеточного рака кожи лица

Συγγραφείς: Sharafutdinova N.A., Musin S.I., Sultanbayev A.V., Menshikov K.V., Ilyin V.V., Ibragimov B.A., Izmailov A.A., Sharifgaliev I.A., Zainullin F.D.

Πηγή: Head and Neck Tumors; Vol 12, No 3 (2022); 141-148 ; Опухоли головы и шеи; Vol 12, No 3 (2022); 141-148 ; 2411-4634 ; 2222-1468

Θεματικοί όροι: metastatic basal cell skin cancer, locally advanced skin cancer, revascularized flaps, метастатический базальноклеточный рак кожи, местно-распространенный рак кожи, реваскуляризированные лоскуты

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/823/551; https://ogsh.abvpress.ru/jour/article/view/823

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/823
https://doi.org/10.17650/2222-1468-2022-12-3-141-148

Intensification of neoadjuvant therapy in patients with locally advanced rectal cancer ; Возможности интенсификации неоадъювантного лечения у больных местно-распространенным раком прямой кишки

Συγγραφείς: Z. Z. Mamedli, A. V. Polynovskiy, D. V. Kuzmichev, S. I. Tkachev, A. A. Aniskin, З. З. Мамедли, А. В. Полыновский, Д. В. Кузьмичев, С. И. Ткачев, А. А. Анискин

Πηγή: Surgery and Oncology; Том 11, № 2 (2021); 19-28 ; Хирургия и онкология; Том 11, № 2 (2021); 19-28 ; 2949-5857

Θεματικοί όροι: химиолучевая терапия, locally advanced rectal cancer, disease-free survival, chemoradiation therapy, местно-распространенный рак прямой кишки, безрецидивная выживаемость

Περιγραφή αρχείου: application/pdf

Relation: https://www.onco-surgery.info/jour/article/view/506/365; Jalil O., Claydon L.A. Review of neoadjuvant chemotherapy alone in locally advanced rectal cancer. J Gastrointest Cancer 2015;46:219–36.; Нафедзов И.О., Чернышов С.В., Пономаренко А.А. и др. Реабилитация пациентов с синдромом низкой передней резекции. Колопроктология 2021;2(76):57–64.; Ковалева Е.В., Синюкова Г.Т., Данзанова Т.Ю. и др. Применение ультразвукового контрастного усиления в диагностике и оценке эффективности химиотерапевтического лечения больных с печеночными метастазами колоректального рака. Вестник рентгенологии и радиологии 2020;101(6):324–32. DOI:10.20862/0042-4676-2020-101-6-324-332.; Ковалева Е.В., Синюкова Г.Т., Данзанова Т.Ю. и др. Оценка возможностей ультразвукового исследования с контрастным усилением в диагностике метастазов колоректального рака в печени. Онкологический журнал: лучевая диагностика, лучевая терапия 2019;2(1):43–50.; Ковалева Е.В., Синюкова Г.Т., Данзанова Т.Ю. и др. Возможности УЗИ с применением контрастного усиления в диагностике метастазов в печени у больных колоректальным раком. Колопроктология 2018;1(63):36–42.; Habr-Gama A., Perez R.O., Nadalin W. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: longterm results. Ann Surg 2004;240:711–7; discussion 717–8.; Maas M., Nelemans P.J., Valentini V. et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010;11(9):835–44.; Garcia-Aguilar J., Chow O.S., Smith D.D. et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicenter, phase 2 trial. Lancet Oncol 2015;16:957–66.; Petrelli F., Sgroi G., Sarti E. et al. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies. Ann Surg 2016;263(3):458–64.

Διαθεσιμότητα: https://www.onco-surgery.info/jour/article/view/506
https://doi.org/10.17650/2686-9594-2021-11-2-19-28

The role of computed and magnetic resonance imaging in assessment of the local advancement of malignant tumors of the hearing organ ; Роль компьютерной и магнитно-резонансной томографии в оценке местной распространенности злокачественных опухолей органа слуха

Συγγραφείς: E. G. Khazarova, E. L. Dronova, Е. Г. Хазарова, Е. Л. Дронова

Πηγή: Head and Neck Tumors (HNT); Том 11, № 2 (2021); 10-17 ; Опухоли головы и шеи; Том 11, № 2 (2021); 10-17 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2021-11-2

Θεματικοί όροι: местно-распространенный рак кожи наружного уха, malignant tumors of the temporal bone, locally advanced outer ear skin cancer, злокачественные опухоли височной кости

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/641/474; Bacciu A., Clemente I.A., Piccirillo E. et al. Guidelines for treating temporal bone carcinoma based on long-term outcomes. Otol Neurotol 2013;34(5):898–907. DOI:10.1097/MAO.0b013e318281e0a9.; Lovin B.D., Gidley P.W. Squamous cell carcinoma of the temporal bone: a current review. Laryngoscope Investig Otolaryngol 2019;4(6):684–92. DOI:10.1002/lio2.330.; Пачес А.И. Опухоли головы и шеи: клиническое руководство. 5-е изд. М.: Практическая медицина, 2013. 478 с.; Мудунов А.М., Бадалян А.Г. Хирургическое лечение местно-распространенного рецидивного рака кожи наружного уха. Случай из практики. Опухоли головы и шеи 2013;3:43–6.; Петрова Л.Г. Лучевая диагностика опухолей височной кости. Новости лучевой диагностики 2002;1:28–9.; Arriaga M., Curtin H., Takahashi H. et al. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 1990;99(9 Pt 1): 714–21. DOI:10.1177/000348949009900909.; Zhiue W., Meizhu Z., Shuang X. The contribution of CT and MRI in staging, treatment planning and prognosis prediction of malignant tumors of external auditory canal. Clin Imaging 2016;40(6):1262–8. DOI:10.1016/j.clinimag.2016.08.020.; Меддер У., Конен М., Андерсен К. и др. Лучевая диагностика. Голова и шея. Пер. с англ. М., 2010. 303 с.; https://ogsh.abvpress.ru/jour/article/view/641

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/641
https://doi.org/10.17650/2222-1468-2021-11-2-10-17

INTRAOPERATIVE PHOTODYNAMIC THERAPY IN PATIENT WITH STAGE IIIC BREAST CANCER (8 YEARS WITHOUT RECURRENCE)

Συγγραφείς: V. I. Chissov, A. D. Zikiryakhodzhaev, E. K. Saribekyan, E. V. Filonenko, A. D. Kaprin, E. V. Rasskazova

Πηγή: Biomedical Photonics, Vol 6, Iss 2, Pp 34-37 (2017)

Θεματικοί όροι: реконструктивно-пластические операции, местно-распространенный рак молочной железы, ТRАМ-лоскут, 01 natural sciences, 3. Good health, breast cancer, locally advanced breast cancer, intraoperative photodynamic therapy, интраоперационная фотодинамическая терапия, photosens, 0103 physical sciences, Medical technology, фотосенс, R855-855.5, тrам-flap, рак молочной железы, reconstructive plastic surgery

Σύνδεσμος πρόσβασης: https://www.pdt-journal.com/jour/article/download/162/162
https://doaj.org/article/54b6dcedee2d4818aad696dfff1d5f4f
https://doaj.org/article/62860fb735d74e23aa8013fecf38fe7f
https://www.pdt-journal.com/jour/article/viewFile/162/162
https://doaj.org/article/54b6dcedee2d4818aad696dfff1d5f4f
https://core.ac.uk/display/87470953
https://www.pdt-journal.com/jour/article/view/162

Novel approaches to treatment of locally advanced rectal cancer ; Современные подходы к лечению местно-распространенного рака прямой кишки

Συγγραφείς: A. A. Kachmazov, L. V. Bolotina, A. L. Kornietskaya, Yu. B. Karagodina, I. V. Droshneva, A. A. Fedenko, А. А. Качмазов, Л. В. Болотина, А. Л. Корниецкая, Ю. Б. Карагодина, И. В. Дрошнева, А. А. Феденко

Πηγή: Surgery and Oncology; Том 10, № 3-4 (2020); 73-83 ; Хирургия и онкология; Том 10, № 3-4 (2020); 73-83 ; 2949-5857

Θεματικοί όροι: консолидирующая химиотерапия, locally advanced cancer, watch-and-wait, neoadjuvant therapy, consolidation chemotherapy, местно-распространенный рак, органосохраняющее лечение, неоадъювантная терапия

Περιγραφή αρχείου: application/pdf

Relation: https://www.onco-surgery.info/jour/article/view/487/354; Практические рекомендации по лекарственному лечению злокачественных опухолей. Под ред. В.М. Моисеенко. Российское общество клинической онкологии, 2019. Доступно по: https://rosoncoweb.ru/standarts/RUSSCO/2019/2019-22.pdf.; NCCN Clinical Practice Guidelines in Oncology – Rectal Cancer. Version 4.2020. National Comprehensive Cancer Network.; Glynne-Jones R., Wyrwicz L., Tiret E. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 2017;28(Suppl 4):iv22–iv40. DOI:10.1093/annonc/mdx224. Available at: https://www.annalsofoncology.org/article/S0923-7534(19)42152-2/abstract.; Клинические рекомендации по лечению онкологических заболеваний. Под ред. А.Д. Каприна. Ассоциация онкологов России, 2020. Доступно по: https://oncology-association.ru/files/clinical-guidelines-2020/rak_prjamoj_kishki.pdf.; MacFarlane J.K., Ryall R.D.H., Heald R.J. Mesorectal excision for rectal cancer. The Lancet 1993;341(8843): 457–60. Available at: https://www.sciencedirect.com/science/article/abs/pii/014067369390207W.; Lambregts D.M.J., Beets-Tan R.G.H. Optimal imaging staging of rectal cancer. Eur J Cancer Suppl 2013;11(2):38–44. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041181/.; Roh M.S., Colangelo L., O’Connell M.J. et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol Off J Am Soc Clin Oncol 2009;27(31):5124–30. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773471/.; Gérard J.-P., Conroy T., Bonnetain F. et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol Off J Am Soc Clin Oncol 2006;24(28):4620–5. Available at: http://estro.dokeos.com/courses/ESTRORECTAL/document/recommended_articles/24-06_JCO_Gerard_FFCD.pdf.; Valentini V., Bonnetain F., Gambacorta M. et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol Off J Am Soc Clin Oncol 2011;29(23):3163–72. Available at: https://www.researchgate.net/profile/Marek_Bebenek/publication/51483716_Nomograms_for_Predicting_Local_Recurrence_Distant_Metastases_and_Overall_Survival_for_Patients_With_Locally_Advanced_Rectal_Cancer_on_the_Basis_of_European_Randomized_Clinical_Trials/links/0a85e53224d63d60e0000000/Nomograms-for-Predicting-Local-Recurrence-Distant-Metastases-and-Overall-Survival-for-Patients-With-Locally-Advanced-Rectal-Cancer-on-the-Basis-of-European-Randomized-Clinical-Trials.pdf.; Bujko K., Nowacki M., Nasierowska‐ Guttmejer A. et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93(10):1215–23. Available at: https://www.ingentaconnect.com/content/jws/bjs/2006/00000093/00000010/art00007.; Ngan S.Y., Bryan B., Goldstein D. et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol Off J Am Soc Clin Oncol 2012;30(31): 3827–33. Available at: https://www.researchgate.net/profile/Stephen_Ackland/publication/231176339_Randomized_Trial_of_Short-Course_Radiotherapy_Versus_Long-Course_Chemoradiation_Comparing_Rates_of_Local_Recurrence_in_Patients_With_T3_Rectal_Cancer_Trans-Tasman_Radiation_Oncology_Group_Trial_0104/links/57fcdef008aed4ab46fe6730/Randomized-Trial-of-Short-Course-Radiotherapy-Versus-Long-Course-Chemoradiation-Comparing-Rates-of-Local-Recurrence-in-Patients-With-T3-Rectal-Cancer-Trans-Tasman-Radiation-Oncology-Group-Trial-0104.pdf.; Francois Y., Nemoz C., Baullieux J. et al. Influence of the interval between preopera tive radiation therapy and surgery on down-staging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 1999;17(8):2396. Available at: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.1010.4888&rep=rep1&type=pdf.; Raymond E., Chaney S., Taamma A., Cvitkovic E. et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol Off J Eur Soc Med Oncol 1998;9(10):1053–71. Available at: https://www.sciencedirect.com/science/article/pii/S0923753419482045.; Goldberg R.M., Gill S. Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer. Cancer Chemother Pharmacol 2004;54(Suppl 1):S57–64. Available at: https://link.springer.com/article/10.1007/s00280-004-0888-9.; Goldberg R.M., Sargent D., Morton R. et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22(1):23–30. Available at: http://www.hayaobio.net/admin/images/file/20141110144845.pdf.; Zhao L., Bai C., Chao Y. et al. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer. Cancer Lett 2011;310(2):134–9. Available at: https://www.sciencedirect.com/science/article/pii/S0304383511003715.; Wang J.-P., Вing W.X., Deng Y.H. et al. Preoperative chemoradiotherapy with FOLFOX in low rectal cancer: a multicenter study. Zhonghua Wei Chang Wai Ke Za Zhi Chin J Gastrointest Surg 2008;11(2):116–9. Available at: https://europepmc.org/article/med/18344075.; Allegra C.J., Yothers G., O’Connell M. et al. Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: A Phase III Randomized Clinical Trial. J Natl Cancer Inst 2015;107(11). Available at: https://academic.oup.com/jnci/article/107/11/djv248/2457689.; Rödel C., Graeven U., Fietkau R. et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2015;16(8):979–89. Available at: https://www.sciencedirect.com/science/article/pii/S147020451500159X.; Zheng J., Feng X., Huet W. et al. Systematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer. Medicine (Baltimore) 2017;96(13):e6487. DOI:10.1097/MD.0000000000006487. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380275/.; De Felice F., Benevento I., Magnante A. et al. Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis: Oxaliplatin in neoadjuvant treatment for rectal cancer. BMC Cancer 2017;17(1):325. Available at: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3323-4.; Tournigand C., Andre T., Achille E. et al. FOLFIRI followed by FOLFOX6 or the re verse sequence in advanced colorec tal cancer: a randomized GERCOR study. J Clin Oncol Off J Am Soc Clin Oncol 2004;22(2):229–37. Available at: http://mauriciolema.webhost4life.com/rolmm/files/GERCOR.pdf.; Klautke G., Küchenmeister U., Foitziket T. al. Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer 2006;94(7):976–81. Available at: https://www.nature.com/articles/6603053.; Jung M., Shin S., Koom W. et al. A randomized phase 2 study of neoadjuvant chemoradiaton therapy with 5-fluorouracil/leucovorin or irinotecan/S-1 in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2015;93(5):1015–22. Available at: https://www.sciencedirect.com/science/article/pii/S0360301615031946.; DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 10 th edn. Philadelphia: LWW, 2014. 2280 p.; Wong S.J., Moughan J., Meropol N. et al. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2015;91(1):116–23. Available at: https://www.sciencedirect.com/science/article/pii/S0360301614041807.; Horisberger K., Treschl A., Mai S. et al. Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. Int J Radiat Oncol Biol Phys 2009; 74(5):1487–93. DOI:10.1016/j.ijrobp.2008.10.014. Available at: https://www.sciencedirect.com/science/article/pii/S0360301608035906.; Eisterer W., de Vries A., Ofner D. et al. Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer – a phase II clinical trial. Anticancer Res 2014;34(11): 6767–73. Available at: http://ar.iiarjournals.org/content/34/11/6767.short.; Rödel C., Arnold D., Hippet M. al. Phase I–II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preopera tive treatment in rectal cancer. Int J Radiat Oncol Biol Phys 2008;70(4):1081–6. Available at: https://www.sciencedirect.com/science/article/pii/S0360301607037790.; De Felice F., Izzo L., Musio D. et al. Clinical predictive factors of pathologic complete response in locally advanced rectal cancer. Oncotarget 2016;7(22):33374–80. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078102/.; Kripp M., Horisberger K., Mai S. et al. Does the addition of cetuximab to radiochemotherapy improve outcome of patients with locally advanced rectal cancer? Long-term results from phase II trials. Gastroenterol Res Pract 2015;2015:273489. DOI:10.1155/2015/273489. Available at: https://www.hindawi.com/journals/grp/2015/273489/.; Benevento I., De Felice F., Musio D., Tombolini V. The addition of target therapy to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a review. Chemotherapy 2017;62(5):314–22. Available at: https://www.karger.com/Article/Abstract/476056.; Pinto C., Fabio F., Maiello E. et al. Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study). Ann Oncol Off J Eur Soc Med Oncol 2011;22(11):2424–30. Available at: https://www.sciencedirect.com/science/article/pii/S0923753419377117.; Mardjuadi F.I., Carrasco J., Coche J. et al. Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer. Target Oncol 2015;10(3):375–83. Available at: https://link.springer.com/article/10.1007/s11523-014-0342-9.; Helbling D., Bodoky G., Gautschi O. et al. Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Ann Oncol Off J Eur Soc Med Oncol 2013;24(3):718–25. Available at: https://www.sciencedirect.com/science/article/pii/S0923753419371455.; Overgaard J., Horsman M. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996;6(1):10–21. Available at: https://www.sciencedirect.com/science/article/pii/S1053429696800324.; Hamming L.C., Slotman B., Verheyul H. et al. The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future. Angiogenesis 2017;20(2):217–32. Available at: https://link.springer.com/content/pdf/10.1007/s10456-017-9546-9.pdf.; Dings R.P.M., Loren M., Heun H. et al. Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res Off J Am Assoc Cancer Res 2007;13(11):3395–402. DOI:10.1158/1078-0432.CCR-06-2441. Available at: https://clincancerres.aacrjournals.org/content/13/11/3395.short.; Lee C.G., Heijn M., di Tomaso E. et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000;60(19):5565–70. Available at: https://cancerres.aacrjournals.org/content/60/19/5565.short.; Willett C.G., Boucher E., di Tomaso E. et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004;10(2):145–7. Available at: https://www.nature.com/articles/nm988.; Kleibeuker E.A., Fokas E., Allen P. et al. Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect. Oncotarget 2016;7(47):76613–27. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363534/.; Winkler F., Kozin S., Tong R. et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004;6(6):553–63. Available at: https://www.sciencedirect.com/science/article/pii/S1535610804003058.; Jain R.K. Molecular regulation of vessel maturation. Nat Med 2003;9(6):685–93. Available at: https://www.nature.com/articles/nm0603-685.; Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307(5706): 58–62. Available at: https://science.sciencemag.org/content/307/5706/58.abstract.; Mayr N.A., Yuh W., Magnotta V. et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996;36(3):623–33. Available at: https://www.sciencedirect.com/science/article/pii/S0360301697850900.; Shibuya K., Tsushima Y., Horisoko E. et al. Blood flow change quantification in cervical cancer before and during radiation therapy using perfusion CT. J Radiat Res (Tokyo) 2011;52(6):804–11. Available at: https://www.jstage.jst.go.jp/article/jrr/52/6/52_11079/article/-char/ja/.; Janssen M.H.M., Aerts H., Kerkelset R. et al. Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findings. Radiother Oncol J Eur Soc Ther Radiol Oncol 2010;94(2):156–60. Available at: https://www.sciencedirect.com/science/article/pii/S0167814009006719.; Borg C., Andre T., Mantion G. et al. Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study. Ann Oncol Off J Eur Soc Med Oncol 2014;25(11):2205–10. Available at: https://www.sciencedirect.com/science/article/pii/S0923753419367717.; Salazar R., Capdevila J., Laquente B. et al. A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer 2015;(15):60. Available at: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1053-z.; Dellas K., Höhler T., Reese T. et al. Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer. Radiat Oncol Lond Engl 2013;(8):90. Available at: https://link.springer.com/article/10.1186/1748-717X-8-90.; Landry J.C., Feng Y., Prabhu R. et al. Phase II trial of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes ECOG-ACRIN Cancer Research Group E3204. The Oncologist 2015;20(6):615–6. DOI:10.1634/theoncologist.2015-0106. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571787/.; Kennecke H., Berry S., Wong R. et al. Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial. Eur J Cancer Oxf Engl 2012;48(1):37–45. Available at: https://www.sciencedirect.com/science/article/pii/S0959804911003492.; Spigel D.R., Bendell J., McCleod M. et al. Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer. Clin Colorectal Cancer 2012;11(1):45–52. Available at: https://www.sciencedirect.com/science/article/pii/S1533002811000338.; Resch G., de Vries A., Ofner D. et al. Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer – a two stage phase II clinical trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 2012;102(1):10–3. Available at: https://www.sciencedirect.com/science/article/pii/S0167814011003197.; Czito B.G., Yu D., Mantyh Ch. et al. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol Off J Am Soc Clin Oncol 2006;24(4):656–62. Available at: https://www.researchgate.net/profile/Christopher_Mantyh/publication/7328246_Increased_Toxicity_With_Gefitinib_Capecitabine_and_Radiation_Therapy_in_Pancreatic_and_Rectal_Cancer_Phase_I_Trial_Results/links/00463533d73eed512c000000/Increased-Toxicity-With-Gefitinib-Capecitabine-and-Radiation-Therapy-in-Pancreatic-and-Rectal-Cancer-Phase-I-Trial-Results.pdf.; Chiang S.-F., Chuang C., Ke T.-W. et al. Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers. Cancer Immunol Immunother 2019;68(2):283–96. Available at: https://link.springer.com/article/10.1007/s00262-018-2275-0.; Rödel C., Hofheinz R., Fokas E. Rectal cancer: Neoadjuvant chemoradiotherapy. Best Pract Res Clin Gastroenterol 2016;30(4):629–39. Available at: https://www.sciencedirect.com/science/article/pii/S1521691816300440.; Fernandez-Martos C. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol 2015;26(8):1722–8. Available at: https://www.sciencedirect.com/science/article/pii/S0923753419318514.; Cercek A., Goodman K. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Cancer Netw JNCCN 2014; 12(4):513–9. Available at: https://jnccn.org/view/journals/jnccn/12/4/article-p513.xml.; Glynne-Jones R., Chau I. Neoadjuvant therapy before surgical treatment. EJC Suppl 2013;11(2):45–59. Available at: https://www.sciencedirect.com/science/article/pii/S1359634913000335.; Habr-Gama A., Perez R.O., Nadalin V. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240(4):711–7; discussion 717–8. DOI:10.1097/01.sla.0000141194.27992.32. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356472/.; Martens M.H., Maas M., Heijnen L.A. et al. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. JNCI J Natl Cancer Inst Oxford Academic 2016;108(12): 171. DOI:10.1093/jnci/djw171. Available at: https://academic.oup.com/jnci/article/108/12/djw171/2706932.

Διαθεσιμότητα: https://www.onco-surgery.info/jour/article/view/487
https://doi.org/10.17650/2686-9594-2020-10-3-4-73-83

Evoluția radioterapiei intracavitare în tratamentul cancerului de col uterin local-avansat.

Συγγραφείς: Cernat, V.F., Чернат, В.Ф., Urechi, V.A., Уреки, В.

Πηγή: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 68 (4) 189-192

Θεματικοί όροι: cancer de col uterin local – avansat, radioterapia intracavitară, brahiterapie, locally advanced cervical cancer, intracavitary radiotherapy, brachytherapy, местно-распространенный рак шейки матки, внутриполостная лучевая терапия, брахитерапия

Περιγραφή αρχείου: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/132209; urn:issn:18570011

Διαθεσιμότητα: https://ibn.idsi.md/vizualizare_articol/132209

INTRAOPERATIVE PHOTODYNAMIC THERAPY IN PATIENT WITH STAGE IIIC BREAST CANCER (8 YEARS WITHOUT RECURRENCE)

Συγγραφείς: A. D. Kaprin, E. V. Rasskazova, E. V. Filonenko, E. K. Saribekyan, A. D. Zikiryakhodzhaev, V. I. Chissov

Πηγή: Biomedical Photonics, Vol 6, Iss 2, Pp 34-37 (2017)

Θεματικοί όροι: рак молочной железы, местно-распространенный рак молочной железы, интраоперационная фотодинамическая терапия, фотосенс, реконструктивно-пластические операции, ТRАМ-лоскут, Medical technology, R855-855.5

Περιγραφή αρχείου: electronic resource

Relation: http://www.pdt-journal.com:80/jour/article/view/162; https://doaj.org/toc/2413-9432

Σύνδεσμος πρόσβασης: https://doaj.org/article/62860fb735d74e23aa8013fecf38fe7f

The importance of surgical treatment of local advanced and disseminated breast cancer. ; Rolul tratamentului chirurgical în cancerul mamar local avansat și diseminat. ; Роль хирургического лечения местно-распространённого - диссеминированного рака молочной железы.

Συγγραφείς: Machidon, Vitalie, Sofroni, Larisa, Sochircă, Diana, Jovmir, Vasile, Badan, Andrei, Machidon, Daniela

Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 64 No. 4 (2019): Medical Sciences; 101-104 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 64 Nr. 4 (2019): Ştiinţe medicale; 101-104 ; Вестник Академии Наук Молдовы. Медицина; Том 64 № 4 (2019): Медицина; 101-104 ; 1857-0011

Θεματικοί όροι: местно-распространённый - рак молочной железы, locally advanced breast cancer, cancer mamar local avansat

Περιγραφή αρχείου: application/pdf

Relation: https://bulmed.md/bulmed/article/view/3148/3148; https://bulmed.md/bulmed/article/view/3148

Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3148

Rolul tratamentului chirurgical în cancerul mamar local avansat și diseminat.

Συγγραφείς: Machidon, V.A., Макидон, В.А., Sofroni, L.I., Софрони, Л.И., Sochircă, D., Jovmir, V.C., Жовмир, В.К., Badan, A., Machidon, D.

Πηγή: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 64 (4) 101-104

Θεματικοί όροι: cancer mamar local avansat, Tratament, locally advanced breast cancer, treatment, местно-распространённый - рак молочной железы

Περιγραφή αρχείου: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/115204; urn:issn:18570011

Διαθεσιμότητα: https://ibn.idsi.md/vizualizare_articol/115204

The peculiarities of surgical service of locally advanced breast cancer after neoadjuvant systemic treatment

Συγγραφείς: O. L. Petrenko

Πηγή: Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 22, Iss 3, Pp 42-47 (2015)

Θεματικοί όροι: neoadjuvant treatment, Medicine (General), 03 medical and health sciences, locally advanced breast cancer, R5-920, 0302 clinical medicine, местно распространенный рак молочной железы, conservative surgery, прогноз, органосохраняющая хирургия, prognostication, неоадъювантная терапия, 3. Good health

Σύνδεσμος πρόσβασης: https://www.sci-notes.ru/jour/article/download/134/132
https://doaj.org/article/6c63e03f9a07418db4fb6d68171a817b
https://www.sci-notes.ru/jour/article/viewFile/134/132

Surgery for advanced oropharyngeal cancer ; Хирургический подход к лечению местно-распространенного рака ротоглотки

Συγγραφείς: A. V. Karpenko, R. R. Sibgatullin, A. A. Boyko, N. S. Chumanikhina, E. Yu. Lomteva, M. V. Lavrova, M. G. Kostova, O. M. Nikolayeva, А. В. Карпенко, Р. Р. Сибгатуллин, А. А. Бойко, Н. С. Чуманихина, E. Ю. Ломтева, М. В. Лаврова, М. Г. Костова, О. М. Николаева

Πηγή: Head and Neck Tumors (HNT); Том 8, № 3 (2018); 37-45 ; Опухоли головы и шеи; Том 8, № 3 (2018); 37-45 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2018-8-3

Θεματικοί όροι: выживаемость, advanced cancer, surgical treatment, survival, местно-распространенный рак, хирургическое лечение

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/359/341; Клинические рекомендации по лечению опухолей головы и шеи Общенациональной онкологической сети (США). М.: АБВ-пресс, 2011. [Clinical practice guidelines in oncology head and neck cancers of the National Comprehensive Cancer Network (USА). Мoscow: АBV-Press, 2011. (In Russ.)].; Пачес А. И. Опухоли головы и шеи. М.: Медицина, 2009. С. 333–334. [Paches A. I. Head and neck tumors. Moscow: Meditsina, 1983. Pp. 333–334. (In Russ.)].; Shah J., Patel S., Singh B. Pharynx and esophagus. In: Jatin Shah’s head and neck surgery and oncology. 4th edn. Philadelphia: Elsevier, 2012. Pp. 290–356.; Daly J., Friedman M. Carcinoma of the tonsil. Laryngoscope 1960;70(5):595–615. DOI:10.1288/00005537‑196005000‑00003. PMID: 13813869.; O’Hara J., MacKenzie K. Surgical versus non-surgical management of early stage oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2011;268(3):437–42. DOI:10.1007/s00405‑010‑1362‑4. PMID: 20799040.; Jaber J. J., Moreira J., Canar W. J., BierLaning C. M. A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2009;135(11):1147–53. DOI:10.1001/archoto.2009.164. PMID: 19917929.; Poulsen M., Porceddu S. V., Kingsley P. A. et al. Locally advanced tonsillar squamous cell carcinoma: treatment approach revisited. Laryngoscope 2007;117(1):45–50. DOI:10.1097/01.mlg.0000243044.91193.32. PMID: 17202929.; Riley R. W., Fee W. E. Jr, Goffinet D. et al. Squamous cell carcinoma of the base of the tongue. Otolaryngol Head Neck Surg 1983;91(2):143–50. DOI:10.1177/019459988309100206. PMID: 6408570.; Parsons J. T., Mendenhall W. M., Stringer S. P. et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002;94(11):2967–80. DOI:10.1002/cncr.10567. PMID: 12115386.; Boscolo-Rizzo P., Gava A., Baggio V. et al. Matched survival analysis in patients with locoregionally advanced resectable oropharyngeal carcinoma: platinum-based induction and concurrent chemoradiotherapy versus primary surgical resection. Int J Radiat Oncol Biol Phys 2011;80(1):154–60. DOI:10.1016/j. ijrobp.2010.01.032. PMID: 20864267.; Shirazi H. A., Sivanandan R., Goode R. et al. Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Head Neck 2006;28(7):587–94. DOI:10.1002/hed.20372. PMID: 16475199.; Allal A., Nicoucar K., Mach N., Dulguerov P. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 2003;25(10):833–9. DOI:10.1002/hed.10302. PMID: 12966507.; Boscolo-Rizzo P., Stellin M., Fuson R. et al. Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: surgery and postoperative radiotherapy versus concurrent chemoradiation. Oral Oncology 2009;45(11):953–7. DOI:10.1016/j.oraloncology.2009.06.005. PMID: 19665919.; Mowry S. E., Ho A., Lotempio M. M. et al. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 2006;116(9):1589–93. DOI:10.1097/ 01.mlg.0000233244.18901.44. PMID: 16954985.; Pourel N., Peiffert D., Lartigau E. et al. Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 2002;54(3):742–51. DOI:10.1016/s0360-3016(02)02959-0. PMID: 12377326.; Ling D. C., Chapman B. V., Kim J. et al. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Oral Oncol 2016;61:41–6. DOI:10.1016/j.oraloncology.2016.08.004. PMID: 27688103.; Haughey B. H., Hinni M. L., Salassa J. R. et al. Transoral laser microsurgery as primary treatment for advance-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011;33(12):1683–94. DOI:10.1002/hed.21669. PMID: 21284056.; Evans M., Jones T. M. Transoral surgery or radiotherapy for oropharyngeal carcinoma: is it either or…? Clin Oncol (R Coll Radiol) 2016;28(7):413–20. DOI:10.1016/j.clon.2016.02.010. PMID: 26988463.; Laccourreye O., Malinvaud D., Alzahrani H. et al. Conventional transoral surgery for stage I–II squamous cell carcinoma of the tonsillar region. Head Neck 2013;35(5):653–9. DOI:10.1002/hed.23018. PMID: 22605677.; Masuda M., Fukushima J., Kadota H. et al. Mandible preserving pull-through oropharyngectomy for advanced oropharyngeal cancer: a pilot study. Auris Nasus Larynx 2011;38(3):392–7. DOI:10.1016/j.anl.2010.08.010. PMID: 20980111.; Garden A. S., Kies M. S., Morrison W. H. et al. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol 2013;8(1):21. DOI:10.1186/1748-717X-8-21. PMID: 23360540.; Chen A. Y., Zhu J., Fedewa S. Temporal trends in oropharyngeal cancer treatment and survival: 1998–2009. Laryngoscope 2014;124(1):131–8. DOI:10.1002/lary.24296. PMID: 23832649.; Tiwana M., Wu J., Hay J. et al. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province. Oral Oncol 2014;50(7):651–6. DOI:10.1016/j.oraloncology. 2014.03.009. PMID: 24731736.; Johnson-Obaseki S., McDonald J.T., Corsten M., Rourke R. Head and neck cancer in Canada: trends 1992 to 2007. Otolaryngol Head Neck Surg 2012;147(1):74–8. DOI:10.1177/0194599812437332. PMID: 22328702.; Nandakumar A., Rath G., Kataki A. et al. Survival in head and neck cancers – results of a multi-institution study. Asian Pac J Cancer Prev 2016;17(4):1745–54. DOI:10.7314/apjcp.2016.17.4.1745. PMID: 27221826.; Wang M., Liu I. Y., Gornbein J. A., Nguyen C. T. HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg 2015;153(5):758–69. DOI:10.1177/0194599815592157. PMID: 26124261.; Mehanna H., Franklin N., Compton N. et al. Geographic variation in human papillomavirus-related oropharyngeal cancer: data from 4 multinational randomized trials. Head Neck 2016;38 Suppl 1: E1863–9. DOI:10.1002/hed.24336. PMID: 26749143.; Rolander T. L., Everts E. C., Shumrick D. A. Carcinoma of the tonsil: a planned combined therapy approach. Laryngoscope 1971;81(8):1199–207. DOI:10.1288/00005537‑197108000‑00003. PMID: 4936465.; Molony P., Kharytaniuk N., Boyle S. et al. Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status. Head Neck 2017;39(8):1680–8. DOI:10.1002/hed.24824. PMID: 28560813.; McMahon J.D., Devine J. C., Hetherington J. et al. Involved surgical margins in oral and oropharyngeal carcinoma – an anatomical problem? Br J Oral Maxillofac Surg 2011;49(3):172–5. DOI:10.1016/j.bjoms.2010.02.014. PMID: 20674106.; Slootweg P. J., Hordijk G. J., Schade Y. et al. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 2002;38(5):500–3. DOI:10.1016/s1368–8375(01) 00092–6. PMID: 12110346.; https://ogsh.abvpress.ru/jour/article/view/359

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/359
https://doi.org/10.17650/2222-1468-2018-8-3-37-45

EXENTERATION OF THE SMALL PELVIS IN TREATMENT OF LOCAL TUMORS

Συγγραφείς: N. A. Maistrenko, A. A. Khvatov, G. V. Uchvatkin, A. A. Sazonov

Πηγή: Вестник хирургии имени И.И. Грекова, Vol 173, Iss 6, Pp 37-42 (2018)

Θεματικοί όροι: тотальная экзентерация малого таза, местно-распространённый рак прямой кишки, опухоли мочеполовой системы, реконструкция органов малого таза, total exenteration, small pelvis, local extended cancer of the rectum, urogenital system tumors, reconstruction of pelvic organs, Surgery, RD1-811

Relation: https://www.vestnik-grekova.ru/jour/article/view/601; https://doaj.org/toc/0042-4625; https://doaj.org/article/7665eeaff16c45089ae8e4803d67b5cc

Διαθεσιμότητα: https://doi.org/10.24884/0042-4625-2014-173-6-37-42
https://doaj.org/article/7665eeaff16c45089ae8e4803d67b5cc

ИНТРАОПЕРАЦИОННАЯ ФОТОДИНАМИЧЕСКАЯ ТЕРАПИЯ БОЛЬНОЙ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ IIIC (8-ЛЕТНИЙ ПЕРИОД БЕЗРЕЦИДИВНОГО НАБЛЮДЕНИЯ)

Πηγή: Biomedical Photonics, Vol 6, Iss 1 (2017)

Θεματικοί όροι: рак молочной железы, местно-распространенный рак молочной железы, интраоперационная фотодинамическая терапия, фотосенс, реконструктивно-пластические операции, ТRАМ-лоскут, Medical technology, R855-855.5

Περιγραφή αρχείου: electronic resource

Relation: http://www.pdt-journal.com/jour/article/view/137; https://doaj.org/toc/2413-9432

Σύνδεσμος πρόσβασης: https://doaj.org/article/6eb5cad3e9064e1c8cb648225ce6d80e

Laparoscopic anterior pelvic exenteration with sigmoid colon resection (clinical observation) ; Лапароскопическая передняя эвисцерация органов малого таза с резекцией сигмовидной кишки (клиническое наблюдение)

Συγγραφείς: A. O. Rasulov, V. A. Aliev, A. I. Ovchinnikova, Kh. E. Dzhumabaev, А. О. Расулов, В. А. Алиев, А. И. Овчинникова, Х. Э. Джумабаев

Πηγή: Surgery and Oncology; Том 7, № 2 (2017); 60-65 ; Хирургия и онкология; Том 7, № 2 (2017); 60-65 ; 2949-5857 ; 10.17650/2220-3478-2017-7-2

Θεματικοί όροι: лапароскопическая резекция сигмовидной кишки, locally advanced cancer, laparoscopic resection of the sigmoid colon, местно-распространенный рак

Περιγραφή αρχείου: application/pdf

Relation: https://www.onco-surgery.info/jour/article/view/220/182; Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948;1(2):177–83. PMID: 18875031.; Широкорад В.И. Хирургическое лечение местно-распроcтраненных опухолей органов малого таза. М.: Медицина, 2008. 192 с. [Shirokorad V.I. Surgical treatment of locally advanced tumours of the pelvic organs. Moscow: Meditsina, 2008. 192 p. (In Russ.)].; Bricker E.M., Modlin J. The role of pelvic evisceration in surgery. Surgery 1970;30:76–93. PMID: 14845996.; Детков И.П., Зыбина М.А., Бялик В.В. Эвисцерация таза при запущенном раке прямой кишки. Вопросы онкологии 1977;(23):90–5. [Detkov I.P., Zybina M.A., Byalik V.V. Evisceration of the pelvis in case of advanced rectal cancer. Voprosy onkologii = Issues of Oncology 1977;(23):90–5. (In Russ.)].; Schmidt A.M., Imesch P., Fink D., Egger H. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol 2012;125(3):604–9. DOI:10.1016/j.ygyno.2012.03.001.; Höckel M., Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 2006;7(10):837–47. DOI:10.1016/S1470-2045(06)70903-2. PMID: 17012046.; Ho Y.H. Techniques for restoring bowel continuity and function after rectal cancer surgery. World J Gastroenterol 2006;21(39):6252–60. PMID: 17072945.; Сhong T.W., Balch G.C., Kehoe S.M.; et al. Reconstruction of large perineal and pelvic wounds using gracilis muscle flaps. Ann Surg Oncol 2015;22(11):3738–44. DOI:10.1245/s10434-015-4435-1.; Burke T.W., Morris M., Roh M.S. et al. Perineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol 1995;57(2):221–5. DOI:10.1006/gyno.1995.1129. PMID: 7729738.; Buchel E.W., Finical S., Johnson C. Pelvic reconstruction using vertical rectus abdominis musculocutaneous flaps. Ann Plast Surg 2004;52(1):22–6. DOI:10.1097/01.sap.0000099820.10065.2a. PMID: 14676694.; Butler C.E., Gundeslioglu A.O., Rodriguez-Bigas M.A. Outcomes of immediate VRAM flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg 2008;206(4):694–703. DOI:10.1016/j.jamcollsurg.2007.12.007.; Holm T., Ljung A., Häggmark T. et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007;94(2):232–8. DOI:10.1002/bjs.5489. PMID: 17143848.; Pawlik T.M., Skibber J.M., Rodriguez- Bigas M.A. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 2006;13(5):612–23. DOI:10.1245/ASO.2006.03.082. PMID: 16538402.; Ferenschild F.T., Vermaas M., Verhoef C. et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009;33(7):1502–8. DOI:10.1007/s00268-009-0066-7.; Selman A.E., Copeland L.J. Surgical management of recurrent cervical cancer. Yonsei Med J 2002;43(6):754–62. DOI:10.3349/ymj.2002.43.6.754. PMID: 12497659.; Höckel M. Laterally extended endopelvic resection (LEER) – principles and practice. Gynecol Oncol 2008; 111(2 Suppl):S13–7. DOI:10.1016/j.ygyno.2008.07.022.; Maggioni A., Roviglione G., Landoni F. et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol 2009;114(1):64–8. DOI:10.1016/j.ygyno.2009.03.029.; Chokshi R.J., Kuhrt M.P., Schmidt C. et al. Single institution experience comparing double-barreled wet colostomy to ileal conduit for urinary and fecal diversion. Urology 2011;78(4):856–62. DOI:10.1016/j.urology.2011.06.030.; Reza M.M., Blasco J.A., Andradas E. et al. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg 2006;93(11):921–8. DOI:10.1002/bjs.5647. PMID: 17058300.; Feliciotti F., Paganini A.M., Guerrieri M. et al. Results of laparoscopic vs open resections for colon cancer in patients with a minimum follow-up of 3 years. Surg Endosc 2002;16(8):1158–61. DOI:10.1007/s00464-001-8333-1.; Ogura A., Akiyoshi T., Konishi T. et al. Safety of Laparoscopic Pelvic Exenteration with Urinary Diversion for Colorectal Malignancies. World J Surg 2016;40(5):1236–43. DOI 10.1007/s00268-015-3364-2.; Uehara K., Nakamura H., Yoshino Y. et al. Initial experience of laparoscopic pelvic ex-enteration and comparison with conventional open surgery. Surg Endosc 2016;30(1): 132–8. DOI:10.1007/s00464-015-4172-3.

Διαθεσιμότητα: https://www.onco-surgery.info/jour/article/view/220
https://doi.org/10.17650/2220-3478-2017-7-2-60-65

CURRENT RECOMMENDATIONS FOR THE TREATMENT OF LOCALLY ADVANCED BREAST CANCER (REVIEW OF LITERATURE) ; СОВРЕМЕННЫЕ РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ МЕСТНО-РАСПРОСТРАНЕННОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ (ОБЗОР ЛИТЕРАТУРЫ) ; СУЧАСНІ РЕКОМЕНДАЦІЇ ЩОДО ЛІКУВАННЯ МІСЦЕВО-ПОШИРЕНОГО РАКУ МОЛОЧНОЇ ЗАЛОЗИ (ОГЛЯД ЛІТЕРАТУРИ)

Συγγραφείς: Seniutovych, R.V., Unguryan, V.P., Kravchuk, S.Yu., Malyshevsky, I.O., Shulgina, V.V., Kushneryk, L.Y., Chuprovska, J.Ya.

Πηγή: Bukovinian Medical Herald; Vol. 21 No. 3 (83) (2017); 154-160 ; Буковинский медицинский вестник; Том 21 № 3 (83) (2017); 154-160 ; Буковинський медичний вісник; Том 21 № 3 (83) (2017); 154-160 ; 2413-0737 ; 1684-7903

Θεματικοί όροι: locally advanced breast cancer, non-adjuvant chemotherapy, местно-распространенный рак молочной железы, неоадювантная химиотерапия, місцево-поширений рак молочної залози, неоад’ювантна хіміотерапія

Περιγραφή αρχείου: application/pdf

Relation: http://e-bmv.bsmu.edu.ua/article/view/2413-0737.XXI.3.83.2017.109/109494

Διαθεσιμότητα: http://e-bmv.bsmu.edu.ua/article/view/2413-0737.XXI.3.83.2017.109
https://doi.org/10.24061/2413-0737.XXI.3.83.2017.109

ИНТРАОПЕРАЦИОННАЯ ФОТОДИНАМИЧЕСКАЯ ТЕРАПИЯ БОЛЬНОЙ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ IIIC (8-ЛЕТНИЙ ПЕРИОД БЕЗРЕЦИДИВНОГО НАБЛЮДЕНИЯ)

Πηγή: Biomedical Photonics, Vol 6, Iss 1 (2017)

Θεματικοί όροι: рак молочной железы, местно-распространенный рак молочной железы, интраоперационная фотодинамическая терапия, фотосенс, реконструктивно-пластические операции, ТRАМ-лоскут, Medical technology, R855-855.5

Relation: http://www.pdt-journal.com/jour/article/view/137; https://doaj.org/toc/2413-9432; https://doaj.org/article/6eb5cad3e9064e1c8cb648225ce6d80e

Διαθεσιμότητα: https://doaj.org/article/6eb5cad3e9064e1c8cb648225ce6d80e

ПРОТОННО-ФОТОННАЯ ЛУЧЕВАЯ ТЕРАПИЯ МЕСТНО-РАСПРОСТРАНЕННОГО РАКА ПРОСТАТЫ

Συγγραφείς: ХМЕЛЕВСКИЙ Е.В., КАНЧЕЛИ И.Н., КАПРИН А.Д.

Θεματικοί όροι: МЕСТНО-РАСПРОСТРАНЕННЫЙ РАК ПРОСТАТЫ,ПРОТОНЫ,РАДИОТЕРАПИЯ,LOCALLY ADVANCED PROSTATE CANCER,PROTON RADIOTHERAPY

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/protonno-fotonnaya-luchevaya-terapiya-mestno-rasprostranennogo-raka-prostaty
http://cyberleninka.ru/article_covers/17002910.png